Back
Charles River Laboratories International Vs. Medpace Holdings Industry Stock Comparison
Buy
52
CRL
Charles River Laboratories International
Last Price:
221.64
Seasonality Move:
7.05%
Buy
62
MEDP
Medpace Holdings
Last Price:
393.03
Seasonality Move:
32.45%
Buy
52
Charles River Laboratories International (CRL)
is a Buy
Is Charles River Laboratories International a Buy, Sell or Hold?
- The current Charles River Laboratories International [CRL] share price is $221.61. The Score for CRL is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- CRL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Medpace Holdings (MEDP)
is a Buy
Is Medpace Holdings a Buy, Sell or Hold?
- The current Medpace Holdings [MEDP] share price is $393.30. The Score for MEDP is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- MEDP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRL Stock Price Chart
What is Charles River Laboratories International's stock price today?
-
The Charles River Laboratories International share price today is $221.61
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRL is experiencing slight selling pressure.
MEDP Stock Price Chart
What is Medpace Holdings's stock price today?
-
The Medpace Holdings share price today is $393.30
The current trend is moderately bearish and MEDP is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.53 | Sell |
| Relative Strength Index (14 RSI): | 35.05 | Sell |
| Chaikin Money Flow: | -460013 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (227.1 - 235.62) | Sell |
| Bollinger Bands (100): | (219.78 - 257.1) | Sell |
MEDP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.88 | Buy |
| Relative Strength Index (14 RSI): | 49.51 | Sell |
| Chaikin Money Flow: | 112337 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (382.93 - 400.85) | Buy |
| Bollinger Bands (100): | (318.38 - 411.06) | Buy |
CRL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 229.21 | Sell |
| 20-day SMA: | 231.57 | Sell |
| 50-day SMA: | 246.28 | Sell |
| 200-day SMA: | 218.2 | Buy |
| 8-day EMA: | 228.31 | Sell |
| 20-day EMA: | 232.33 | Sell |
| 50-day EMA: | 237.97 | Sell |
| 200-day EMA: | 226.74 | Sell |
MEDP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 394.66 | Sell |
| 20-day SMA: | 394.81 | Sell |
| 50-day SMA: | 396.47 | Sell |
| 200-day SMA: | 314.67 | Buy |
| 8-day EMA: | 395.47 | Sell |
| 20-day EMA: | 394.71 | Sell |
| 50-day EMA: | 388.47 | Buy |
| 200-day EMA: | 327.21 | Buy |
Charles River Laboratories International Earnings Growth & CRL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.66 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.42 per share, and an increase next year of $1.40 per share.
Medpace Holdings Earnings Growth & MEDP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.72 per share, a decrease next quarter of $0.05 per share, an increase this year of $2.42 per share, and an increase next year of $1.97 per share.
Charles River Laboratories International Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Medpace Holdings Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||